Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Magazine Issues

March Issue of The Medicine Maker

From battling river blindness, to Ebola, to the threat of the coronavirus – March’s cover feature looks at how pharma is standing up to neglected tropical diseases and emerging pathogens. George Chressanthis explains why the coronavirus will have an economic impact on the pharma industry and what companies can do about it; and we catch up with new CEO, Stuart Young, about his change in role and the trends driving the business of clinical trials. In addition, Claudia Zylberberg makes the case for a regulatory framework for cell and gene ancillary materials; while the latest news, views and research, include a new polio vaccine, structure elucidation for natural products, and advice for budding entrepreneurs in the UK. We also sit down with “pharmaceutical nomad” and Chief Executive Officer at Bone Therapeutics, Miguel Forte.

Download Issue Articles in this issue

Previous issues 2020